Q2 2023 Holdings
Filed 2023-08-14 | 93 holdings | $2.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Becton Dickinson & Co(BDX) | COM | 075887109 | $105.1M | 398,050 | 3.7% |
| Karuna Therapeutics Inc | COM | 48576A100 | $95.9M | 442,200 | 3.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $87.1M | 702,778 | 3.0% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $84.9M | 1,045,400 | 3.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $80.6M | 990,500 | 2.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $71.8M | 184,300 | 2.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $70.2M | 2,985,700 | 2.5% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $70.0M | 1,555,000 | 2.4% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $69.8M | 518,400 | 2.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $68.8M | 2,773,189 | 2.4% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $65.8M | 2,334,000 | 2.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $62.7M | 665,316 | 2.2% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $62.4M | 133,000 | 2.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $60.1M | 2,872,000 | 2.1% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $58.4M | 370,100 | 2.0% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $57.9M | 152,600 | 2.0% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $57.7M | 300,000 | 2.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $57.7M | 4,337,400 | 2.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $55.1M | 798,900 | 1.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $49.6M | 174,000 | 1.7% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $47.9M | 1,025,000 | 1.7% |
| Curevac N V | COM | N2451R105 | $44.8M | 4,300,000 | 1.6% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $43.8M | 550,000 | 1.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $43.7M | 875,000 | 1.5% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $43.2M | 101,200 | 1.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $42.7M | 468,700 | 1.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $42.5M | 785,700 | 1.5% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $41.5M | 900,700 | 1.5% |
| Pfizer Inc(PFE) | COM | 717081103 | $41.0M | 1,117,467 | 1.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $39.6M | 2,085,000 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $39.2M | 545,000 | 1.4% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $37.7M | 1,997,800 | 1.3% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $37.4M | 217,000 | 1.3% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $36.5M | 535,000 | 1.3% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $35.0M | 1,425,000 | 1.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $34.5M | 575,000 | 1.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $34.1M | 297,500 | 1.2% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $33.0M | 925,000 | 1.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $31.7M | 1,325,000 | 1.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $28.8M | 1,075,000 | 1.0% |
| Privia Health Group Inc(PRVA) | COM | 74276R102 | $28.2M | 1,079,806 | 1.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $27.9M | 1,949,700 | 1.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $27.6M | 604,700 | 1.0% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $26.6M | 5,700,000 | 0.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $26.3M | 1,326,000 | 0.9% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $26.2M | 415,000 | 0.9% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $24.7M | 3,000,000 | 0.9% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $22.7M | 692,500 | 0.8% |
| Natera Inc(NTRA) | COM | 632307104 | $21.1M | 432,900 | 0.7% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $20.6M | 245,100 | 0.7% |